HomeNRSN • NASDAQ
Follow
Neurosense Therapeutics Ltd
Previous close
$1.65
Day range
$1.56 - $1.64
Year range
$0.40 - $2.33
Market cap
27.73M USD
Avg Volume
215.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
NVDA
3.87%
0.58%
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.29M | -2.72% |
Net income | -2.95M | 6.35% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.28M | 2.79% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.64M | -62.76% |
Total assets | 3.18M | -58.81% |
Total liabilities | 5.05M | 141.51% |
Total equity | -1.87M | — |
Shares outstanding | 15.60M | — |
Price to book | -13.75 | — |
Return on assets | -191.95% | — |
Return on capital | 891.27% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -2.95M | 6.35% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2017
Website
Employees
18